Expected Health Benefits of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Older Adults.

Autor: Dadwani RS; Pritzker School of Medicine, University of Chicago, Chicago, IL, USA., Wan W; Department of Medicine, University of Chicago, Chicago, IL, USA., Skandari MR; Imperial College Business School, Imperial College London, London, UK., Huang ES; Department of Medicine, University of Chicago, Chicago, IL, USA.

Publikováno v: MDM policy & practice [MDM Policy Pract] 2023 Jul 20; Vol. 8 (2), pp. 23814683231187566. Date of Electronic Publication: 2023 Jul 20 (Print Publication: 2023).

First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study.

Autor: Choi JG; Section of General Internal Medicine, Department of Medicine, University of Chicago, Chicago, Illinois (J.G.C., M.I.F., E.M.S., J.A., M.Z.)., Winn AN; Medical College of Wisconsin, Milwaukee, Wisconsin (A.N.W.)., Skandari MR; Centre for Health Economics & Policy Innovation, Imperial College Business School, Imperial College London, London, United Kingdom (M.R.S.)., Franco MI; Section of General Internal Medicine, Department of Medicine, University of Chicago, Chicago, Illinois (J.G.C., M.I.F., E.M.S., J.A., M.Z.)., Staab EM; Section of General Internal Medicine, Department of Medicine, University of Chicago, Chicago, Illinois (J.G.C., M.I.F., E.M.S., J.A., M.Z.)., Alexander J; Section of General Internal Medicine, Department of Medicine, University of Chicago, Chicago, Illinois (J.G.C., M.I.F., E.M.S., J.A., M.Z.)., Wan W; Section of General Internal Medicine and Center for Chronic Disease Research and Policy, Department of Medicine, University of Chicago, Chicago, Illinois (W.W., E.S.H., N.L.)., Zhu M; Section of General Internal Medicine, Department of Medicine, University of Chicago, Chicago, Illinois (J.G.C., M.I.F., E.M.S., J.A., M.Z.)., Huang ES; Section of General Internal Medicine and Center for Chronic Disease Research and Policy, Department of Medicine, University of Chicago, Chicago, Illinois (W.W., E.S.H., N.L.)., Philipson L; Sections of Adult and Pediatric Endocrinology, Diabetes & Metabolism, Department of Medicine, University of Chicago, Chicago, Illinois (L.P.)., Laiteerapong N; Section of General Internal Medicine and Center for Chronic Disease Research and Policy, Department of Medicine, University of Chicago, Chicago, Illinois (W.W., E.S.H., N.L.).

Publikováno v: Annals of internal medicine [Ann Intern Med] 2022 Oct; Vol. 175 (10), pp. 1392-1400. Date of Electronic Publication: 2022 Oct 04.

The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis.

Autor: Alexander JT; Department of Medicine, University of Chicago, Chicago, IL, USA. jalexander3@medicine.bsd.uchicago.edu., Staab EM; Department of Medicine, University of Chicago, Chicago, IL, USA., Wan W; Department of Medicine, University of Chicago, Chicago, IL, USA., Franco M; Department of Medicine, University of Chicago, Chicago, IL, USA., Knitter A; Department of Medicine, University of Chicago, Chicago, IL, USA., Skandari MR; Centre for Health Economics and Policy Innovation, Imperial College Business School, London, UK., Bolen S; Department of Medicine, Case Western Reserve University, Cleveland, OH, USA., Maruthur NM; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Huang ES; Department of Medicine, University of Chicago, Chicago, IL, USA., Philipson LH; Department of Medicine, University of Chicago, Chicago, IL, USA., Winn AN; Department of Clinical Sciences, Medical College of Wisconsin, Milwaukee, WI, USA., Thomas CC; Department of Medicine, University of Chicago, Chicago, IL, USA., Zeytinoglu M; Department of Medicine, University of Chicago, Chicago, IL, USA., Press VG; Department of Medicine, University of Chicago, Chicago, IL, USA., Tung EL; Department of Medicine, University of Chicago, Chicago, IL, USA., Gunter K; Department of Medicine, University of Chicago, Chicago, IL, USA., Bindon B; Department of Medicine, National Jewish Health, Denver, CO, USA., Jumani S; Department of Medicine, University of Chicago, Chicago, IL, USA., Laiteerapong N; Department of Medicine, University of Chicago, Chicago, IL, USA.

Publikováno v: Journal of general internal medicine [J Gen Intern Med] 2022 Feb; Vol. 37 (2), pp. 415-438. Date of Electronic Publication: 2021 Sep 10.

The Productivity Requirements of Implementing a Medical Scribe Program.

Autor: Miksanek TJ; Pritzker School of Medicine, University of Chicago, Chicago, Illinois (T.J.M., W.W.L., V.G.P., N.L.)., Skandari MR; Centre for Health Economics and Policy Innovation, Imperial College Business School, Imperial College London, London, United Kingdom (M.R.S.)., Ham SA; Center for Health and the Social Sciences, University of Chicago, Chicago, Illinois (S.A.H.)., Lee WW; Pritzker School of Medicine, University of Chicago, Chicago, Illinois (T.J.M., W.W.L., V.G.P., N.L.)., Press VG; Pritzker School of Medicine, University of Chicago, Chicago, Illinois (T.J.M., W.W.L., V.G.P., N.L.)., Brown MT; Rush Medical College, Chicago, Illinois (M.T.B.)., Laiteerapong N; Pritzker School of Medicine, University of Chicago, Chicago, Illinois (T.J.M., W.W.L., V.G.P., N.L.).

Publikováno v: Annals of internal medicine [Ann Intern Med] 2021 Jan; Vol. 174 (1), pp. 1-7. Date of Electronic Publication: 2020 Oct 06.

The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing.

Autor: GoodSmith MS; Pritzker School of Medicine, University of Chicago, Chicago, IL matthew.goodsmith@uchospitals.edu., Skandari MR; Imperial College Business School, Imperial College London, London, U.K., Huang ES; Section of General Internal Medicine, University of Chicago, Chicago, IL., Naylor RN; Section of Adult and Pediatric Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, IL.

Publikováno v: Diabetes care [Diabetes Care] 2019 Dec; Vol. 42 (12), pp. 2247-2255. Date of Electronic Publication: 2019 Sep 26.